Caxton Associates LP Cytokinetics Inc Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$29.74 - $46.0 $282,113 - $436,356
-9,486 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$34.35 - $46.38 $325,844 - $439,960
9,486 New
9,486 $432,000
Q2 2020

Aug 14, 2020
SELL
$11.15 - $24.64 $146,901 - $324,632
-13,175 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$8.75 - $16.3 $115,281 - $214,752
13,175 New
13,175 $155,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email